← Back
$AKBA All transactions

Akebia Therapeutics, Inc.

A

$ Value

$0

Shares

35,700

Price

$0

Filed

Jun 11

Insider

Name

GILMAN STEVEN C

Title

CIK

0001379970

Roles

Director

Transaction Details

Transaction Date

2025-06-10

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

152,830

Footnotes

The restricted stock units (the "RSUs") were granted by the Issuer pursuant to its 2023 Stock Incentive Plan (the "2023 Plan"), as provided by the Issuer's Fourth Amended and Restated Non-Employee Director Compensation Program (the "Program"). The RSUs will vest in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer. | The option to purchase shares of the Issuer's common stock (the "Stock Option") was granted by the Issuer pursuant to the 2023 Plan, as provided by the Program. The Stock Option will vest and become exercisable in full (100%) on the first anniversary of the grant date (or, if earlier, immediately prior to the first annual meeting of the Company's stockholders occurring after the date of grant), subject to the Reporting Person's continued service to the Issuer.

Filing Info

Accession No.

0001562180-25-004719

Form Type

4

Issuer CIK

0001517022

GILMAN STEVEN C's History

Date Ticker Type Value
2025-06-26 SCYX A $0
2025-06-26 SCYX A $0
2025-06-10 AKBA A $0
2025-06-10 AKBA A $0

Other Insiders at AKBA (90d)

Insider Bought Sold Last
Vickers Philip J. 2026-04-01